HomeACET • NASDAQ
Adicet Bio Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 29.89M | -3.19% |
Net income | -28.21M | -0.71% |
Net profit margin | — | — |
Earnings per share | -0.31 | 11.43% |
EBITDA | -28.21M | 3.47% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 150.44M | -39.24% |
Total assets | 191.27M | -34.74% |
Total liabilities | 29.83M | -13.02% |
Total equity | 161.45M | — |
Shares outstanding | 82.71M | — |
Price to book | 0.34 | — |
Return on assets | -36.31% | — |
Return on capital | -39.16% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -28.21M | -0.71% |
Cash from operations | -25.40M | -11.15% |
Cash from investing | -2.86M | -1,097.07% |
Cash from financing | -104.00K | -100.09% |
Net change in cash | -28.36M | -132.27% |
Free cash flow | -17.38M | -21.62% |
Previous close
$0.67
Day range
$0.67 - $0.70
Year range
$0.45 - $1.70
Market cap
55.52M USD
Avg Volume
646.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Headquarters
Website
Employees
152